RBCC: Mobile Technology May Help Reduce Athletes’ Risk of Brain Injury

  RBCC: Mobile Technology May Help Reduce Athletes’ Risk of Brain Injury

Business Wire

NOKOMIS, Fla. -- October 31, 2012

As Rainbow Coral Corp. (OTCBB: RBCC) works to help eliminate the public health
threat posed by traumatic brain injury (TBI), a new smartphone app could prove
key to reducing the serious risk of concussion faced by athletes in contact
sports.

Thanks in part to a $1.5 million government grant, Hockey Canada has developed
a new smartphone app aimed at keeping players safe from brain injury. The app
includes medically approved information on everything from concussion symptoms
to return-to-play protocols, designed to help coaches, trainers and players
quickly diagnose concussions suffered in the course of play and respond
accordingly.

Available across all mobile platforms, the app can be updated immediately with
the latest advances in TBI research, helping to keep athletes as informed on
concussions as leading doctors are.

“The potential for this technology to change the way concussions are handled
in sports is huge,” said RBCC CEO Patrick Brown. “Apps can be customized not
only for hockey, but for football and other rough sports and deployed on
sidelines and trainers’ rooms around the world instantaneously. It’s precisely
the kind of technological advance that could help eliminate the risk of TBI to
our athletes.”

RBCC is striving to capitalize on the growing demand for effective new
treatments for TBI and other neurological health issues. The company is
continuing discussions with the license holders for a NASA-developed
bioreactor that assists in the expansion of adult stem cells useful in the
development of potential cures. Such treatments could give RBCC access to
markets in excess of $100 billion.

Rainbow BioSciences is dedicated to developing new medical and research
technology innovations to compete alongside companies such as Amgen Inc.
(NASDAQ:AMGN),Cell Therapeutics, Inc. (NASDAQ: CTIC), Abbott Laboratories
(NYSE:ABT) andAffymax, Inc.(NASDAQ:AFFY).

For more information on Rainbow BioSciences, please visit
www.rainbowbiosciences.com/investors.

Follow us on Twitter atwww.twitter.com/RBCCinfo.

About Rainbow BioSciences

Rainbow BioSciences is a division ofRainbow Coral Corp.(OTCBB:RBCC). The
company continually seeks out new partnerships with biotechnology developers
to deliver profitable new medical technologies and innovations. For more
information on our growth-oriented business initiatives, please visit our
website at www.rainbowbiosciences.com. For investment information and
performance data on the company, please
visitwww.RainbowBioSciences.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipate" or similar
expressions. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information included
herein for events occurring after the date hereof.

Contact:

Rainbow Coral Corp.
Patrick Brown, 813-367-9511
President and CEO
info@rainbowcoral.com
 
Press spacebar to pause and continue. Press esc to stop.